Skip to content

Roivant Sciences ROIV Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$21M-320%
AbbVie logo
AbbVieABBV
$22M+229%
Regenxbio logo
RegenxbioRGNX
-$19K-290%
Amgen logo
AmgenAMGN
Moderna logo
ModernaMRNA

Other financials

Income statement

See full
Revenue$2.5M-66.7%
Operating income-$339.2M-23.6%
Net income-$265.9M-257%
EPS (diluted)-$0.38-265%

Balance sheet

See full
Cash & equivalents$1.4B+1,411%
Total debt$107.4M+7.3%
Total equity$4.5B-3.4%
Total assets$5.7B+5.0%

Cash flow

See full
Operating cash flow-$163.8M+5.1%
CapEx$1.3M+55.5%
Free cash flow-$165.1M+4.8%

Valuation

See full
Market cap$26.48B+263%
Enterprise value$25.16B+244%
P/S3,205.4×+2,891×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-9,183.5%-17,093pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio18.4×-15.1×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Roivant Sciences’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Roivant Sciences's other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Roivant Sciences's other noncash income (expense)?
Roivant Sciences (ROIV) reported other noncash income (expense) of -$5.98M in Q3 2025.
How has Roivant Sciences's other noncash income (expense) changed year-over-year?
Roivant Sciences's other noncash income (expense) decreased by 133.3% year-over-year, from $17.94M to -$5.98M.
What is the long-term trend for Roivant Sciences's other noncash income (expense)?
Over 2 years (2022 to 2024), Roivant Sciences's other noncash income (expense) has grown at a -57.9% compound annual growth rate (CAGR), from $21.21M to -$3.76M.
What does other noncash income (expense) mean?
This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.